| [1] |
HUANG Wei-Jia, LI Zhang-Ping, CHEN Shou-Quan, WANG Wei, WANGMing-Shan, WANG Wang-Tie, LU Zhong-Qiu.
Effects of ulinastatin for injection (UTI) on cytokines and ultrastructure of brain tissue after cardiopulmonary-cerebral-resuscitation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(9): 1057-1060.
|
| [2] |
ZHANG Hong-Tao, YUAN Shou-Jun, LI Zheng-Qiang.
Progress of caspase inhibitors in pharmacology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(3): 241-244.
|
| [3] |
QI Hong, Leroy MJ1, Advenier C2, ZHANG Yong, Emmanuel N2, CHEN Hong-Zhuang.
Effects of a novel phosphodiesterase IV inhibitor Ariflo on endothelin-1-induced contractility of isolated human uterine myometrium
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(3): 299-301.
|
| [4] |
CHEN Chun-Lei, CHEN Cao-Zhen, LIN Hui.
Clinical evaluation on ulinastatin in treatment ofPatients with acutePan-creatitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(5): 570-572.
|
| [5] |
.
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1998, 3(2): 152-153.
|
| [6] |
.
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1997, 2(3): 173-173.
|
| [7] |
HUANG Wei-jia, CHEN Shou-quan, WANG Wan-tie, LI Hui-ping, CHENG Jun-yan, ZHAO Chuhuan, LI Zhang-ping, WANG Ming-shan, WANG Wei.
Effect of Xingnaojing injection on metabolism of arachidonic acid in rabbits following cerebral ischemia-reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(10): 1171-1174.
|
| [8] |
DENG Xiao-lan, LI Hui, JING Xian, TIAN Ying-ying, LV Pei-yu, OUYANG Dong-sheng.
Recent progress of aldose reductase in non-diabetic disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(5): 590-594.
|
